1 week Ago By Defense World Staff
Orion Portfolio Solutions LLC lessened its stake in Mettler-Toledo International Inc. (NYSE:MTD – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the SEC.
The institutional investor owned 557 shares of the medical instruments supplier’s stock after selling 13 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in Mettler-Toledo International were worth $682,000 at the end of the most recent reporting period. Several other institutional investors also recently bought and sold shares of the stock.
Pictet Asset Management Holding SA grew its position in shares of Mettler-Toledo International by 14.4% during the fourth quarter. Pictet Asset Management Holding SA now owns 12,654 shares of the medical instruments supplier’s stock valued at $15,484,000 after purchasing an additional 1,591 shares in the last quarter.
Nomura Asset Management Co. Ltd. grew its holdings in Mettler-Toledo International by 0.
4% during the 4th quarter. Nomura Asset Management Co. Ltd.
now owns 8,489 shares of the medical instruments supplier’s stock valued at $10,388,000 after buying an additional 30 shares in the last quarter. Norges Bank bought a new stake in Mettler-Toledo International in the 4th quarter worth approximately $372,954,000. Loomis Sayles & Co.
L P raised its holdings in shares of Mettler-Toledo International by 5.2% during the 4th quarter. Loomis Sayles & Co.
L P now owns 220,780 shares of the medical instruments supplier’s stock worth $270,164,000 after acquiring an additional 10,878 shares in the last quarter. Finally, UniSuper Management Pty Ltd boosted its position in shares of Mettler-Toledo International by 32.1% during the 4th quarter.
UniSuper Management Pty Ltd now owns 2,218 shares of the medical instruments supplier’s stock valued at $2,714,000 after acquiring an additional 539 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.
Mettler-Toledo International Stock PerformanceShares of MTD stock opened at $1,021.97 on Monday. The stock has a 50 day moving average price of $1,264.
13 and a 200 day moving average price of $1,293.69. Mettler-Toledo International Inc.
has a 52-week low of $1,000.72 and a 52-week high of $1,546.93.
The firm has a market capitalization of $21.30 billion, a P/E ratio of 25.22, a P/E/G ratio of 3.
30 and a beta of 1.28. Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, February 13th.
The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.
65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.
29%. As a group, sell-side analysts forecast that Mettler-Toledo International Inc. will post 42.
71 EPS for the current year. Analyst Upgrades and DowngradesA number of equities research analysts recently issued reports on the stock. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,450.
00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Friday, December 13th.
They issued a “peer perform” rating for the company. Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.
00 and gave the stock an “equal weight” rating in a research note on Monday, February 10th. Citigroup lowered their price objective on Mettler-Toledo International from $1,450.00 to $1,400.
00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Finally, Robert W. Baird boosted their target price on Mettler-Toledo International from $1,362.
00 to $1,369.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock.
According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $1,380.50.View Our Latest Report on MTDInsiders Place Their BetsIn related news, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th.
The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10.
Following the transaction, the insider now owns 734 shares of the company’s stock, valued at $964,248.46. This represents a 51.
84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction on Monday, February 10th.
The shares were sold at an average price of $1,351.34, for a total value of $810,804.00.
Following the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.
01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.
94% of the company’s stock. About Mettler-Toledo International (Free Report)Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.
S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured StoriesFive stocks we like better than Mettler-Toledo InternationalDo ETFs Pay Dividends? What You Need to KnowNewsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?How to Calculate Stock Profit Disney 2025 Shareholders: Major Updates for InvestorsHow to Invest in Biotech StocksAdvance Auto Parts Stock: A Classic Rebound Play in the Making.
